143 related articles for article (PubMed ID: 2676043)
41. Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Stamatoullas A; Fruchart C; Bastit D; Boulet D; Moncondult M; Piguet H; Tilly H
Cancer; 1996 Jun; 77(11):2302-7. PubMed ID: 8635099
[TBL] [Abstract][Full Text] [Related]
42. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W
Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474
[TBL] [Abstract][Full Text] [Related]
43. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
Bone Marrow Transplant; 1996 Feb; 17(2):149-55. PubMed ID: 8640159
[TBL] [Abstract][Full Text] [Related]
44. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
Dann EJ; Daugherty CK; Larson RA
Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
[TBL] [Abstract][Full Text] [Related]
45. Intensive therapy and autotransplantation in Hodgkin's disease.
Reece DE; Phillips GL
Stem Cells; 1994 Sep; 12(5):477-93. PubMed ID: 7804123
[TBL] [Abstract][Full Text] [Related]
46. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.
Philip T; Guglielmi C; Hagenbeek A; Somers R; Van der Lelie H; Bron D; Sonneveld P; Gisselbrecht C; Cahn JY; Harousseau JL
N Engl J Med; 1995 Dec; 333(23):1540-5. PubMed ID: 7477169
[TBL] [Abstract][Full Text] [Related]
47. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
48. Indications and relative indications for stem cell transplantation in non-Hodgkin's lymphoma.
Stewart FM
Leukemia; 1993 Jul; 7(7):1091-4. PubMed ID: 8100601
[TBL] [Abstract][Full Text] [Related]
49. Bone morphology after bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Michelson JD; Gornet M; Codd T; Torres J; Lanighan K; Jones R
Exp Hematol; 1993 Mar; 21(3):475-82. PubMed ID: 8440346
[TBL] [Abstract][Full Text] [Related]
50. Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.
Liu HW; Seftel MD; Rubinger M; Szwajcer D; Demers A; Nugent Z; Schroeder G; Butler JB; Cooke A
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):513-20. PubMed ID: 20137862
[TBL] [Abstract][Full Text] [Related]
51. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
52. [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients].
Wang H; Cui X; Shao Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):436-8. PubMed ID: 11810783
[TBL] [Abstract][Full Text] [Related]
53. Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
Bearman SI; Appelbaum FR; Back A; Petersen FB; Buckner CD; Sullivan KM; Schoch HG; Fisher LD; Thomas ED
J Clin Oncol; 1989 Sep; 7(9):1288-94. PubMed ID: 2671286
[TBL] [Abstract][Full Text] [Related]
54. Dose-escalated total body irradiation and autologous stem cell transplantation for refractory hematologic malignancy.
McAfee SL; Powell SN; Colby C; Spitzer TR
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):151-6. PubMed ID: 12007954
[TBL] [Abstract][Full Text] [Related]
55. The therapeutic and biological effects of total lymph node irradiation and autologous bone marrow infusion on malignant lymphoma patients.
Yu S; Chen Z; Chen Y; Jiang C; Guo T; Jiang B; Gao P; Kong X
Chin Med Sci J; 1991 Dec; 6(4):197-202. PubMed ID: 1813057
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Herzig RH; Coccia PF; Strandjord SE; Warkintin PI; Cheung NK; Gordon EM; Novak L; Shina D
Semin Oncol; 1987 Jun; 14(2 Suppl 1):139-40. PubMed ID: 3296203
[No Abstract] [Full Text] [Related]
57. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Herzig RH; Coccia PF; Lazarus HM; Strandjord SE; Graham-Pole J; Cheung NK; Gordon EM; Gross S; Spitzer TR; Warkentin PI
Semin Oncol; 1985 Jun; 12(2 Suppl 3):184-6. PubMed ID: 3892700
[No Abstract] [Full Text] [Related]
58. Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial.
Petersen FB; Deeg HJ; Buckner CD; Appelbaum FR; Storb R; Clift RA; Sanders JE; Bensinger WI; Witherspoon RP; Sullivan KM
Int J Radiat Oncol Biol Phys; 1992; 23(5):1027-32. PubMed ID: 1639636
[TBL] [Abstract][Full Text] [Related]
59. Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle.
Petersen FB; Appelbaum FR; Hill R; Fisher LD; Bigelow CL; Sanders JE; Sullivan KM; Bensinger WI; Witherspoon RP; Storb R
J Clin Oncol; 1990 Apr; 8(4):638-47. PubMed ID: 2313333
[TBL] [Abstract][Full Text] [Related]
60. High-dose cytosine arabinoside in non-Hodgkin's lymphoma.
Kantarjian H; Barlogie B; Plunkett W; Velasquez W; McLaughlin P; Riggs S; Cabanillas F
J Clin Oncol; 1983 Nov; 1(11):689-94. PubMed ID: 6366130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
